Clarithromycin in adult-onset Still's disease. Case report with 1-year follow-up [6]

Clinical and Experimental Rheumatology

Volumn 22, Issue 3, 2004, Pages 379-

  Saviola, Gianantonio ^a   Abdi Ali, L ^a   Shams Eddin, S ^a   Davoli, C ^b   Taglietti, M ^c  

^a IRCCS   (Italy)

^b S Camilo Hospital   (Italy)

^c Rheumatology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISONE; STEROID;

ADULT; ADULT ONSET STILL DISEASE; ARTHROPATHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HEADACHE; HUMAN; HYPERPYREXIA; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; STERNOCLAVICULAR JOINT; URTICARIA;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 2342613597     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. IANARO A, IALENTI A, MAFFIA P et al.: Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000, 292: 1-8.
2. SAVIOLA G, ABDI ALI L, ROSSINI et al.: Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: An open, uncontrolled pilot study. Clin Exp Rheumatol 2002; 20: 373-8.
3. TERAO, H, ASANO K, KANAI K et al.: Suppressive activity of macrolide antibiotics on mtnc oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm 2003; 12: 195-202.
4. MIYAZAKI M, ZAITSU M, HONJO K et al.: Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 229-35.
5. KREMER JM, HABROS JS, KOLBA KS et al.: Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six month, open-label study. Arthritis Rheum 2003; 48: 2763-8.
6. FURST DE, SAAG K, FLEISCHMANN MR et al.: Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double blind, randomized, dose-ranging study. Arthritis Rheum 2002; 46: 2020-8.
7. KOVARIK JM, BURTIN P: Immunosuppressant in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opin Emerg Drugs 2003; 8: 47-62.
8. DROSOS AA: Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy. Drugs 2002; 62: 891-907.